Cancer & Metabolism (Jan 2023)

Arginase-1 inhibition reduces migration ability and metastatic colonization of colon cancer cells

  • Xiangdong Wang,
  • Huihui Xiang,
  • Yujiro Toyoshima,
  • Weidong Shen,
  • Shunsuke Shichi,
  • Hiroki Nakamoto,
  • Saori Kimura,
  • Ko Sugiyama,
  • Shigenori Homma,
  • Yohei Miyagi,
  • Akinobu Taketomi,
  • Hidemitsu Kitamura

DOI
https://doi.org/10.1186/s40170-022-00301-z
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Background Arginase-1 (ARG1), a urea cycle-related enzyme, catalyzes the hydrolysis of arginine to urea and ornithine, which regulates the proliferation, differentiation, and function of various cells. However, it is unclear whether ARG1 controls the progression and malignant alterations of colon cancer. Methods We established metastatic colonization mouse model and ARG1 overexpressing murine colon cancer CT26 cells to investigate whether activation of ARG1 was related to malignancy of colon cancer cells in vivo. Living cell numbers and migration ability of CT26 cells were evaluated in the presence of ARG inhibitor in vitro. Results Inhibition of arginase activity significantly suppressed the proliferation and migration ability of CT26 murine colon cancer cells in vitro. Overexpression of ARG1 in CT26 cells reduced intracellular l-arginine levels, enhanced cell migration, and promoted epithelial-mesenchymal transition. Metastatic colonization of CT26 cells in lung and liver tissues was significantly augmented by ARG1 overexpression in vivo. ARG1 gene expression was higher in the tumor tissues of liver metastasis than those of primary tumor, and arginase inhibition suppressed the migration ability of HCT116 human colon cancer cells. Conclusion Activation of ARG1 is related to the migration ability and metastatic colonization of colon cancer cells, and blockade of this process may be a novel strategy for controlling cancer malignancy.

Keywords